National Storage Mechanism | Additional information
RNS Number : 0373U
Citadel Group
23 March 2023
 

Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.             KEY INFORMATION

 

(a)   Full name of discloser

Citadel Group

(b)   Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c)   Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

HORIZON THERAPEUTICS PLC

(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

N/A

(e)   Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

22 March 2023

(f)    In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2.             INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.



 

Ap28

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

 

Class of relevant security
(Note 3)

Common Stock ISIN IE00BQPVQZ61


Interests

Short positions

Number

%

Number

%

(1)   Relevant securities owned and/or controlled

4,100,289

1.79

236

0.00

(2)   Cash-settled derivatives

0

0.00

0

0.00

(3)   Stock-settled derivatives (including options) and agreements to purchase/ sell

0

0.00

0

0.00

Total

4,100,289

1.79

236

0.00

 

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3.             DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)           Purchases and sales

 

Class of relevant
security

Purchase/sale

Number of
securities

Price per unit
(Note 5)

 Common

Buy Transaction

21,715

107.3200 USD

 Common

Buy Transaction

94

107.4805 USD

 Common

Buy Transaction

165

107.4905 USD

 Common

Buy Transaction

156

107.4906 USD

 Common

Buy Transaction

397

107.4911 USD

 Common

Buy Transaction

26

107.4925 USD

 Common

Buy Transaction

76

107.4959 USD

 Common

Buy Transaction

100

107.5150 USD

 Common

Buy Transaction

39

107.6095 USD

 Common

Buy Transaction

800

107.6850 USD

 Common

Buy Transaction

22

107.6950 USD

 Common

Buy Transaction

219

107.7077 USD

 Common

Buy Transaction

92

107.7142 USD

 Common

Buy Transaction

44

107.7143 USD

 Common

Buy Transaction

87

107.7147 USD

 Common

Buy Transaction

17

107.7506 USD

 Common

Buy Transaction

117

107.8146 USD

 Common

Buy Transaction

289

107.8239 USD

 Common

Buy Transaction

42

107.8412 USD

 Common

Buy Transaction

18,487

107.8580 USD

 Common

Buy Transaction

38

107.8617 USD

 Common

Buy Transaction

349

107.8644 USD

 Common

Buy Transaction

175

107.8662 USD

 Common

Buy Transaction

855

107.8665 USD

 Common

Buy Transaction

344

107.8713 USD

 Common

Buy Transaction

142

107.8761 USD

 Common

Buy Transaction

78

107.8920 USD

 Common

Buy Transaction

46

107.8960 USD

 Common

Buy Transaction

170

107.9226 USD

 Common

Buy Transaction

413

107.9238 USD

 Common

Buy Transaction

29

107.9250 USD

 Common

Buy Transaction

85

107.9254 USD

 Common

Buy Transaction

300

107.9300 USD

 Common

Buy Transaction

156

107.9513 USD

 Common

Buy Transaction

46

107.9574 USD

 Common

Buy Transaction

61

107.9670 USD

 Common

Buy Transaction

207

107.9782 USD

 Common

Buy Transaction

126

107.9833 USD

 Common

Buy Transaction

610

107.9837 USD

 Common

Buy Transaction

38

107.9838 USD

 Common

Buy Transaction

246

107.9840 USD

 Common

Buy Transaction

7

107.9857 USD

 Common

Buy Transaction

42

107.9964 USD

 Common

Buy Transaction

107

107.9986 USD

 Common

Buy Transaction

22

107.9989 USD

 Common

Buy Transaction

212

108.0012 USD

 Common

Buy Transaction

501

108.0046 USD

 Common

Buy Transaction

201

108.0060 USD

 Common

Buy Transaction

101

108.0096 USD

 Common

Buy Transaction

566

108.0202 USD

 Common

Buy Transaction

8

108.0206 USD

 Common

Buy Transaction

759

108.0354 USD

 Common

Buy Transaction

163

108.0404 USD

 Common

Buy Transaction

13

108.0423 USD

 Common

Buy Transaction

36

108.0594 USD

 Common

Buy Transaction

98

108.0599 USD

 Common

Buy Transaction

93

108.0599 USD

 Common

Buy Transaction

234

108.0600 USD

 Common

Buy Transaction

48

108.0600 USD

 Common

Buy Transaction

19

108.0603 USD

 Common

Buy Transaction

3

108.0617 USD

 Common

Buy Transaction

2,335

108.0696 USD

 Common

Buy Transaction

935

108.0697 USD

 Common

Buy Transaction

1,839

108.0703 USD

 Common

Buy Transaction

478

108.0712 USD

 Common

Buy Transaction

4,480

108.0788 USD

 Common

Buy Transaction

1,819

108.0812 USD

 Common

Buy Transaction

916

108.0814 USD

 Common

Buy Transaction

391

108.0819 USD

 Common

Buy Transaction

2

108.0850 USD

 Common

Buy Transaction

38

108.0958 USD

 Common

Buy Transaction

21

108.1098 USD

 Common

Buy Transaction

9,246

108.1135 USD

 Common

Buy Transaction

7

108.1143 USD

 Common

Buy Transaction

38

108.1182 USD

 Common

Buy Transaction

99

108.1214 USD

 Common

Buy Transaction

30

108.1248 USD

 Common

Buy Transaction

56

108.1307 USD

 Common

Buy Transaction

14

108.1364 USD

 Common

Buy Transaction

253

108.1385 USD

 Common

Buy Transaction

200

108.1400 USD

 Common

Buy Transaction

724

108.1442 USD

 Common

Buy Transaction

66

108.1470 USD

 Common

Buy Transaction

415

108.1489 USD

 Common

Buy Transaction

1,032

108.1506 USD

 Common

Buy Transaction

210

108.1517 USD

 Common

Buy Transaction

121

108.1601 USD

 Common

Buy Transaction

78

108.1713 USD

 Common

Buy Transaction

468

108.1718 USD

 Common

Buy Transaction

507

108.1739 USD

 Common

Buy Transaction

250

108.1755 USD

 Common

Buy Transaction

1,235

108.1764 USD

 Common

Buy Transaction

15,050

108.1850 USD

 Common

Buy Transaction

112

108.1992 USD

 Common

Buy Transaction

2,736

108.2135 USD

 Common

Buy Transaction

9,225

108.2486 USD

 Common

Buy Transaction

200

108.3100 USD

 Common

DVP Transaction

1,939

107.3200 USD

 Common

RVP Transaction

1,939

107.3200 USD

 Common

Sell Transaction

1,939

107.3200 USD

 Common

Sell Transaction

300

107.9567 USD

 Common

Sell Transaction

274

108.0381 USD

 Common

Sell Transaction

2,486

108.1248 USD

 Common

Sell Transaction

1,396

108.1499 USD

 Common

Sell Transaction

512

108.1632 USD

 Common

Sell Transaction

100

108.2500 USD



 

Ap29

 

(b)           Cash-settled derivative transactions

 

Class of
relevant
security

Product
description
e.g. CFD

Nature of dealing
e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of
reference
securities
(Note 6)

Price
per unit
(Note 5)

 

(c)           Stock-settled derivative transactions (including options)

 

(i)            Writing, selling, purchasing or varying

 

Class of
relevant
security

Product
description e.g. call
option

Writing, purchasing, selling, varying
etc.

Number
of
securities
to which
option
relates
(Note 6)

Exercise
price per

unit

Type
e.g.
American,
European
etc.

Expiry
date

Option
money
paid/

received per unit

 

(ii)           Exercise

 

Class of
relevant
security

Product
description
e.g. call
option

Exercising/
exercised
against

Number of
securities

Exercise
price per
unit
(Note 5)

 

(d)           Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of
relevant
security

Nature of dealing
e.g. subscription,
conversion, exercise

Details

Price per unit (if
applicable)
(Note 5)

 

 

 

 



 

Ap30

 

4.             OTHER INFORMATION

 

(a)           Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 None

 

(b)           Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 None

 

(c)           Attachments

 

Is a Supplemental Form 8 attached?

NO

 

Date of disclosure

23 March 2023

Contact name

Paula Sharp

Telephone number

020 7645 9700

 

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEPPUWWWUPWGGW